920729.BJ北京证券交易所 · 北交所 BSE
Winsunbio 永顺生物
Animal Health 动物保健Ⅱ
¥6.54−¥0.01 · −0.15%
Open 开盘
¥6.63
High 最高
¥6.64
Low 最低
¥6.50
Prev Close 昨收
¥6.55
Volume 成交量
47.5万股
Turnover 成交额
¥312.4万
Mkt Cap 总市值
¥18亿
P/E 市盈率
64.0×
Recent Activity 近期动态All Filings 全部公告 →
7 significant filings since 31 May 2026: 3 on buyback, 3 on equity incentive and 1 on dividend. The latest, on 24 Jul 2026: 回购股份注销完成暨股份变动公告.
自 31 May 2026 起有 7 份重大公告：buyback 3 份、equity incentive 3 份、dividend 1 份。最新一份（24 Jul 2026）：回购股份注销完成暨股份变动公告。
Price History 价格走势
66 trading days 个交易日 · High 最高 ¥7.52 · Low 最低 ¥6.166.256.506.757.007.257.50
Volume 成交量
553.4万
26 Jun20 Jul11 Aug03 Sep28 Sep
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Animal Health 动物保健Ⅱ · 12 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥18亿 | ¥38亿 | 3rd lowest of 12 · 12 家中第 3 低 | |
| Trailing P/E 市盈率 | 64.0x | 48.9x | 4th highest of 9 · 9 家中第 4 高 | |
| P/B 市净率 | 2.7x | 2.1x | 4th highest of 12 · 12 家中第 4 高 | |
| Revenue Growth 营收增速 | -28.1% | 0.0% | Lowest of 12 · 12 家中第 1 低 | |
| Profit Growth 净利增速 | -67.5% | -36.2% | 3rd lowest of 12 · 12 家中第 3 低 | |
| Gross Margin 毛利率 | 54.4% | 38.8% | 4th highest of 12 · 12 家中第 4 高 | |
| Net Margin 净利率 | 7.3% | 8.3% | 6th lowest of 12 · 12 家中第 6 低 | |
| Return on Equity 净资产收益率 | 0.9% | 2.3% | 5th lowest of 12 · 12 家中第 5 低 | |
| Debt to Assets 资产负债率 | 12.7% | 23.4% | 4th lowest of 12 · 12 家中第 4 低 | |
| Grade Score 评级得分 | 41 | 54 | 5th lowest of 12 · 12 家中第 5 低 |
Statement figures are for the period to 30 Jun 2026, filed by 12 of 12 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，12 家同业中 12 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Jinyu 生物股份 | ¥126亿 | 87.3x | 2.3x | 22.1% | 14.7% | 1.9% | C |
| Tianjin Ringpu Bio-Technology 瑞普生物 | ¥77亿 | 22.1x | 1.6x | 0.8% | 12.9% | 4.3% | C |
| China Animal Husbandry 中牧股份 | ¥68亿 | 48.9x | 1.2x | 13.5% | 2.3% | 0.9% | D |
| Keqian Biology 科前生物 | ¥57亿 | 18.0x | 1.4x | -23.3% | 30.7% | 2.8% | C |
| Jinhe Biotechnology 金河生物 | ¥43亿 | 210.0x | 1.7x | 4.1% | 9.3% | 5.7% | C |
| Wuhan HVSEN Biotechnology 回盛生物 | ¥42亿 | 12.2x | 1.8x | 5.2% | 23.9% | 9.1% | C |
| Pulike 普莱柯 | ¥35亿 | 24.0x | 1.4x | -12.2% | 13.0% | 3.0% | C |
| Lifecome Biochemistry 绿康生化 | ¥34亿 | — | 48.6x | -15.7% | 2.8% | 10.9% | C |
| Shen Lian Biomedical 申联生物 | ¥34亿 | — | 2.5x | -8.1% | -18.2% | -1.4% | D |
| Winsunbio 永顺生物 | ¥18亿 | 64.0x | 2.7x | -28.1% | 7.3% | 0.9% | D |
| Drive 驱动力 | ¥10亿 | 457.4x | 4.6x | -0.8% | -1.6% | -0.2% | D |
| Dayu Biological 大禹生物 | ¥6.95亿 | — | 2.9x | 15.7% | -36.9% | -10.6% | E |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。